Skip to main content
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.33
-0.26 (-2.24%)
At close: Apr 28, 2026, 4:00 PM EDT
11.33
0.00 (0.00%)
After-hours: Apr 28, 2026, 5:16 PM EDT

Phathom Pharmaceuticals Revenue

In the year 2025, Phathom Pharmaceuticals had annual revenue of $175.11M with 216.93% growth. Phathom Pharmaceuticals had revenue of $57.58M in the quarter ending December 31, 2025, with 94.12% growth.

Revenue (ttm)
$175.11M
Revenue Growth
+216.93%
P/S Ratio
5.15
Revenue / Employee
$471,995
Employees
371
Market Cap
899.94M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025175.11M119.86M216.93%
Dec 31, 202455.25M54.57M8,001.47%
Dec 31, 2023682.00K--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Maravai LifeSciences Holdings 185.74M
Geron 183.88M
Xencor 125.58M
CytomX Therapeutics 76.20M
Evommune 13.00M
Janux Therapeutics 10.00M
Compass Therapeutics 850.00K
Revenue Rankings

PHAT News

More News